Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 12 | $1,743,307 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 30 Jan 2025 12:12 | APLS | Apellis Pharmaceuticals Inc | LEWIS KAREN | Chief People Officer | 29 Jan 2025 | Sale | 364 | 29.5236 | 10,747 | D |
| 23 Jan 2025 15:29 | APLS | Apellis Pharmaceuticals Inc | LEWIS KAREN | Chief People Officer | 22 Jan 2025 | Sale | 1,751 | 30.4255 | 53,275 | D |
| 21 Jan 2025 16:07 | APLS | Apellis Pharmaceuticals Inc | LEWIS KAREN | Chief People Officer | 17 Jan 2025 | Sale | 1,241 | 29.9582 | 37,178 | D |
| 14 Jan 2025 16:20 | APLS | Apellis Pharmaceuticals Inc | LEWIS KAREN | Chief People Officer | 13 Jan 2025 | Sale | 1,599 | 28.7021 | 45,895 | D |
| 31 Jan 2024 16:28 | APLS | Apellis Pharmaceuticals Inc | LEWIS KAREN | Chief People Officer | 30 Jan 2024 | Sale | 883 | 65.53 | 57,863 | D |
| 31 Jan 2024 16:28 | APLS | Apellis Pharmaceuticals Inc | LEWIS KAREN | Chief People Officer | 29 Jan 2024 | Sale | 367 | 64.1382 | 23,539 | D |
| 24 Jan 2024 16:06 | APLS | Apellis Pharmaceuticals Inc | LEWIS KAREN | Chief People Officer | 23 Jan 2024 | Sale | 4,286 | 63.69 | 272,975 | D |
| 23 Jan 2024 18:07 | APLS | Apellis Pharmaceuticals Inc | LEWIS KAREN | Chief People Officer | 22 Jan 2024 | Sale | 1,738 | 64.996 | 112,963 | D |
| 18 Jan 2024 16:54 | APLS | Apellis Pharmaceuticals Inc | LEWIS KAREN | Chief People Officer | 17 Jan 2024 | Sale | 3,276 | 65.58 | 214,840 | D |
| 17 Jan 2024 16:43 | APLS | Apellis Pharmaceuticals Inc | LEWIS KAREN | Chief People Officer | 16 Jan 2024 | Sale | 1,632 | 66.8086 | 109,032 | D |
| 02 Jun 2023 16:40 | APLS | Apellis Pharmaceuticals Inc | LEWIS KAREN | Chief People Officer | 01 Jun 2023 | Sale | 5,000 | 86 | 430,000 | D |
| 05 Apr 2023 16:52 | APLS | Apellis Pharmaceuticals Inc | LEWIS KAREN | Chief People Officer | 03 Apr 2023 | Sale | 5,000 | 75 | 375,000 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)